Patent ID: 11925703
Assignee: XELLIA PHARMACEUTICALS APS
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 14:
15. A method of treating a human having metabolic acidosis, wherein the method consists essentially of: (i) preparing the aqueous composition in a unit dosage form, the composition consisting of glucose in a concentration from 1 mg/ml to 50 mg/ml, sodium bicarbonate in concentration from 4 mg/ml to 15 mg/ml, a pH adjusting agent, water, and a pH control agent to adjust the pH, wherein the pH of the composition is from 6.7 to 8.1; (ii) storing the unit dosage form for at last 3 months at room temperature after the preparation; and (iii) after storing, administering the unit dosage form to the human; wherein the unit dosage form that is administered to the human contains less than or equal to 1% of fructose as determined by HPLC.